| Product Code: ETC9677190 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand API CDMO Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand API CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand API CDMO Market - Industry Life Cycle |
3.4 Thailand API CDMO Market - Porter's Five Forces |
3.5 Thailand API CDMO Market Revenues & Volume Share, By Molecule Type, 2021 & 2031F |
3.6 Thailand API CDMO Market Revenues & Volume Share, By Synthesis, 2021 & 2031F |
3.7 Thailand API CDMO Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Thailand API CDMO Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Thailand API CDMO Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Thailand API CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for complex and high-value APIs in the pharmaceutical industry |
4.2.2 Growing trend of outsourcing API manufacturing to reduce costs and focus on core competencies |
4.2.3 Favorable government regulations and policies supporting the development of the CDMO market in Thailand |
4.3 Market Restraints |
4.3.1 Intense competition from established CDMO providers in other countries |
4.3.2 Challenges related to maintaining quality standards and regulatory compliance in API manufacturing |
4.3.3 Fluctuations in raw material prices impacting the production costs of APIs |
5 Thailand API CDMO Market Trends |
6 Thailand API CDMO Market, By Types |
6.1 Thailand API CDMO Market, By Molecule Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand API CDMO Market Revenues & Volume, By Molecule Type, 2021- 2031F |
6.1.3 Thailand API CDMO Market Revenues & Volume, By Small Molecule, 2021- 2031F |
6.1.4 Thailand API CDMO Market Revenues & Volume, By Large Molecule, 2021- 2031F |
6.2 Thailand API CDMO Market, By Synthesis |
6.2.1 Overview and Analysis |
6.2.2 Thailand API CDMO Market Revenues & Volume, By Biotech, 2021- 2031F |
6.2.3 Thailand API CDMO Market Revenues & Volume, By Synthetic, 2021- 2031F |
6.3 Thailand API CDMO Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Thailand API CDMO Market Revenues & Volume, By Innovative, 2021- 2031F |
6.3.3 Thailand API CDMO Market Revenues & Volume, By Generics, 2021- 2031F |
6.4 Thailand API CDMO Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Thailand API CDMO Market Revenues & Volume, By Clinical, 2021- 2031F |
6.4.3 Thailand API CDMO Market Revenues & Volume, By Commercial, 2021- 2031F |
6.5 Thailand API CDMO Market, By Application |
6.5.1 Overview and Analysis |
6.5.2 Thailand API CDMO Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Thailand API CDMO Market Revenues & Volume, By Oncology, 2021- 2031F |
6.5.4 Thailand API CDMO Market Revenues & Volume, By Ophthalmology, 2021- 2031F |
6.5.5 Thailand API CDMO Market Revenues & Volume, By Neurology, 2021- 2031F |
6.5.6 Thailand API CDMO Market Revenues & Volume, By Orthopedic, 2021- 2031F |
7 Thailand API CDMO Market Import-Export Trade Statistics |
7.1 Thailand API CDMO Market Export to Major Countries |
7.2 Thailand API CDMO Market Imports from Major Countries |
8 Thailand API CDMO Market Key Performance Indicators |
8.1 Capacity utilization rate of API manufacturing facilities in Thailand |
8.2 Number of new partnerships and collaborations with pharmaceutical companies |
8.3 Percentage of revenue allocated to research and development for innovative API manufacturing processes |
9 Thailand API CDMO Market - Opportunity Assessment |
9.1 Thailand API CDMO Market Opportunity Assessment, By Molecule Type, 2021 & 2031F |
9.2 Thailand API CDMO Market Opportunity Assessment, By Synthesis, 2021 & 2031F |
9.3 Thailand API CDMO Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Thailand API CDMO Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Thailand API CDMO Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Thailand API CDMO Market - Competitive Landscape |
10.1 Thailand API CDMO Market Revenue Share, By Companies, 2024 |
10.2 Thailand API CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here